Literature DB >> 12090795

Outbreak of a susceptible strain of Acinetobacter species 13 (sensu Tjernberg and Ursing) in an adult neurosurgical intensive care unit.

H van Dessel1, T E M Kamp-Hopmans, A C Fluit, S Brisse, A M G A de Smet, L Dijkshoorn, A Troelstra, J Verhoef, E M Mascini.   

Abstract

Between December 1999 and June 2000, an outbreak caused by Acinetobacter emerged on the neurosurgical intensive care unit of our hospital. It was shown using automated ribotyping using Eco RI and pulsed-field gel electrophoresis that the outbreak was caused by spread of a single strain, which was identified by ribotyping and amplified ribosomal DNA restriction analysis as Acinetobacter DNA group 13TU (sensu Tjernberg and Ursing). The outbreak strain, which showed no antibiotic resistance, was identified in 23 patients, five of whom developed an infection. The organism was also isolated from various environmental sites. Cross-transmission among patients continued despite contact isolation of colonized patients and reinforcement of basic disinfection procedures. Eventually, after implementation of additional stringent measures such as cohorting of positive patients and daily disinfection of the floor, the outbreak was brought under control. This study demonstrates that apart from Acinetobacter baumanii, Acinetobacter 13TU strains, even when they are fully susceptible, may cause outbreaks that are difficult to control. Correct identification to the species level of Acinetobacter by genotypic methods is necessary to get insight in the importance of the different Acinetobacter genomic species in hospital epidemiology. Copyright 2002 The Hospital Infection Society.

Entities:  

Mesh:

Year:  2002        PMID: 12090795     DOI: 10.1053/jhin.2002.1212

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  14 in total

1.  The K1 capsular polysaccharide of Acinetobacter baumannii strain 307-0294 is a major virulence factor.

Authors:  Thomas A Russo; Nicole R Luke; Janet M Beanan; Ruth Olson; Shauna L Sauberan; Ulrike MacDonald; L Wayne Schultz; Timothy C Umland; Anthony A Campagnari
Journal:  Infect Immun       Date:  2010-07-19       Impact factor: 3.441

2.  Identification of Acinetobacter genomic species 13TU by sequence analysis of the 16S-23S rRNA gene spacer region.

Authors:  Raffaele Zarrilli; Maria Giannouli; Anna Di Popolo; Federica Tomasone; Yiu-Wai Chu; Mario Vaneechoutte; Lenie Dijkshoorn; Tsung Chain Chang
Journal:  J Clin Microbiol       Date:  2009-04       Impact factor: 5.948

3.  Dissemination of Acinetobacter nosocomialis clone among critically ill patients and the environment.

Authors:  Valéria Brígido de Carvalho Girão; Natacha Martins; Luciana Camila Cacci; Talita Coelho-Souza; Simone Aranha Nouér; Lee W Riley; Beatriz Meurer Moreira
Journal:  J Clin Microbiol       Date:  2013-05-22       Impact factor: 5.948

4.  Identification of Acinetobacter species and genotyping of Acinetobacter baumannii by multilocus PCR and mass spectrometry.

Authors:  Joseph A Ecker; Christian Massire; Thomas A Hall; Raymond Ranken; Thuy-Trang D Pennella; Cristina Agasino Ivy; Lawrence B Blyn; Steven A Hofstadler; Timothy P Endy; Paul T Scott; Luther Lindler; Tacita Hamilton; Charla Gaddy; Kerry Snow; Marie Pe; Joel Fishbain; David Craft; Gregory Deye; Scott Riddell; Eric Milstrey; Bruno Petruccelli; Sylvain Brisse; Vanessa Harpin; Amy Schink; David J Ecker; Rangarajan Sampath; Mark W Eshoo
Journal:  J Clin Microbiol       Date:  2006-08       Impact factor: 5.948

5.  The K1 capsular polysaccharide from Acinetobacter baumannii is a potential therapeutic target via passive immunization.

Authors:  Thomas A Russo; Janet M Beanan; Ruth Olson; Ulrike MacDonald; Andrew D Cox; Frank St Michael; Evgeny V Vinogradov; Brad Spellberg; Nicole R Luke-Marshall; Anthony A Campagnari
Journal:  Infect Immun       Date:  2013-01-07       Impact factor: 3.441

6.  Incidence of Acinetobacter species other than A. baumannii among clinical isolates of Acinetobacter: evidence for emerging species.

Authors:  Jane F Turton; Jayesh Shah; Chika Ozongwu; Rachel Pike
Journal:  J Clin Microbiol       Date:  2010-02-24       Impact factor: 5.948

7.  The population structure of Acinetobacter baumannii: expanding multiresistant clones from an ancestral susceptible genetic pool.

Authors:  Laure Diancourt; Virginie Passet; Alexandr Nemec; Lenie Dijkshoorn; Sylvain Brisse
Journal:  PLoS One       Date:  2010-04-07       Impact factor: 3.240

8.  Comparison of genospecies and antimicrobial resistance profiles of isolates in the Acinetobacter calcoaceticus-Acinetobacter baumannii complex from various clinical specimens.

Authors:  Ni Tien; Bang-Jau You; Hui-Lan Chang; Hsiu-Shen Lin; Chin-Yi Lee; Tung-Ching Chung; Jang-Jih Lu; Chao-Chin Chang
Journal:  Antimicrob Agents Chemother       Date:  2012-09-24       Impact factor: 5.191

9.  Rat pneumonia and soft-tissue infection models for the study of Acinetobacter baumannii biology.

Authors:  Thomas A Russo; Janet M Beanan; Ruth Olson; Ulrike MacDonald; Nicole R Luke; Steven R Gill; Anthony A Campagnari
Journal:  Infect Immun       Date:  2008-06-09       Impact factor: 3.441

10.  Endemic and epidemic acinetobacter species in a university hospital: an 8-year survey.

Authors:  P J van den Broek; T J K van der Reijden; E van Strijen; A V Helmig-Schurter; A T Bernards; L Dijkshoorn
Journal:  J Clin Microbiol       Date:  2009-09-30       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.